Canadian Blood Services and its independent Research Ethics Board (REB) review all studies involving human participants conducted by or on behalf of Canadian Blood Services, including studies involving personal information (data) or biologic materials (products) collected by Canadian Blood Services.
Investigators must submit an application to have their studies approved. The review process includes the following steps:
Step 1: Approval by Canadian Blood Services.
Step 2: Approval by Canadian Blood Services REB, if required. The REB has three scheduled meetings per year (in early June, October, and March). Additional reviews can be organized throughout the year, as needed.
Step 3: Execution of an agreement between Canadian Blood Services and the Principal Investigator/Organization, if required.
The decision to approve a study depends on the information provided in the application. Investigators must share any new knowledge that changes this information with Canadian Blood Services through an amendment. Investigators must also inform Canadian Blood Services of incidental findings and privacy breaches.
Research Ethics Board Position Available!
The Canadian Blood Services Research Ethics Board is recruiting for the position(s) listed below. If you are interested in this opportunity, please submit your application as detailed in the job description below to CBSREB@blood.ca.
Each position will be advertised for a minimum of one month and will remain posted until a suitable candidate has been found. All applications will be acknowledged by the Research Ethics Program secretariat.
Investigators must complete one Part A and one or more Part B, depending on the nature of the application. Review the Application Guidelines and the Application Forms for details. Contact CBSREB@blood.ca for assistance.
Investigators are required to notify Canadian Blood Services of any modifications to their approved studies. Modifications must first be approved by Canadian Blood Services and its independent REB, if required, before changes can be implemented unless subject safety is at risk. Modifications include, but are not limited to, changes to Principal Investigator, co-Investigator(s), or primary contact.
Canadian Blood Services approvals are granted for a period of one year and must be renewed on an annual basis. A maximum of four renewals may be granted (i.e., for an overall study period of five years).
Investigators are required to immediately report to Canadian Blood Services all serious adverse events occurring to a research participant enrolled in their studies. Incidental findings and minor adverse events must be reported within seven days.
Investigators are required to immediately (or within 24 hours) report to Canadian Blood Services any suspected privacy incidents involving a research participant’s personal information to firstname.lastname@example.org.
A suspected privacy incident is an event or situation (intentional or unintentional) that has or may have resulted in the inappropriate collection, use (including access or modification), disclosure, disposal, or destruction of personal information.
Close an approved study
Investigators are required to report the termination of their studies to Canadian Blood Services.